Compounds > methylprednisolone

methylprednisolone and dronabinol

methylprednisolone has been researched along with dronabinol in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (45.45)	29.6817
2010's	3 (27.27)	24.3611
2020's	3 (27.27)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dicpinigaitis, PV; Fakier, F; Suhrland, MJ; Teka, M; Trachuk, P	1
Bellinghausen, A; Golts, E; Odish, MF; Owens, RL	1
Markowski, LM; Maslonka, MA; Miller, PJ; Schertz, AR	1

Reviews

1 review(s) available for methylprednisolone and dronabinol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

10 other study(ies) available for methylprednisolone and dronabinol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Identification of clinically used drugs that activate pregnane X receptors. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:1 Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics	2011
Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia. Lung, 2020, Volume: 198, Issue:1 Topics: Administration, Inhalation; Adult; Bronchoscopy; Cannabidiol; Cannabis; Dronabinol; Electronic Nicotine Delivery Systems; Glucocorticoids; Humans; Hypoxia; Intubation, Intratracheal; Macrophages, Alveolar; Male; Methylprednisolone; Plant Oils; Pneumonia, Lipid; Respiration, Artificial; Respiratory Insufficiency; Tomography, X-Ray Computed; Vaping	2020
E-cigarette, or vaping, product use-associated lung injury (EVALI) treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO) and ultra-protective ventilator settings. BMJ case reports, 2020, Jul-02, Volume: 13, Issue:7 Topics: Anti-Inflammatory Agents; Dronabinol; Electronic Nicotine Delivery Systems; Extracorporeal Membrane Oxygenation; Hospitalization; Humans; Intensive Care Units; Lung Injury; Male; Methylprednisolone; Psychotropic Drugs; Respiration, Artificial; Respiratory Distress Syndrome; Tidal Volume; Treatment Outcome; Vaping; Young Adult	2020
Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI). BMJ case reports, 2020, Sep-02, Volume: 13, Issue:9 Topics: Acute Lung Injury; Analgesia; Computed Tomography Angiography; Deep Sedation; Dose-Response Relationship, Drug; Dronabinol; Electronic Nicotine Delivery Systems; Female; Humans; Hypnotics and Sedatives; Intubation, Intratracheal; Lung; Methylprednisolone; Pain, Procedural; Propofol; Respiration, Artificial; Respiratory Insufficiency; Time Factors; Vaping; Young Adult	2020